Clinic Factors Associated With Mailed Fecal Immunochemical Test (FIT) Completion: The Difference-Making Role of Support Staff.

Melinda M Davis, Jennifer L Schneider, Amanda F Petrik, Edward J Miech, Brittany Younger, Anne L Escaron, Jennifer S Rivelli, Jamie H Thompson, Denis Nyongesa, Gloria D Coronado
Author Information
  1. Melinda M Davis: Oregon Rural Practice-Based Research Network, Department of Family Medicine, and School of Public Health, Oregon Health & Science University, Portland, Oregon davismel@ohsu.edu.
  2. Jennifer L Schneider: Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
  3. Amanda F Petrik: Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
  4. Edward J Miech: Regenstrief Institute, Center for Health Services Research, Indianapolis, Indiana.
  5. Brittany Younger: AltaMed Institute for Health Equity, AltaMed Health Services Corporation, Los Angeles, California.
  6. Anne L Escaron: AltaMed Institute for Health Equity, AltaMed Health Services Corporation, Los Angeles, California.
  7. Jennifer S Rivelli: Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
  8. Jamie H Thompson: Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
  9. Denis Nyongesa: Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
  10. Gloria D Coronado: Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.

Abstract

PURPOSE: Mailed fecal immunochemical test (FIT) programs can facilitate colorectal cancer (CRC) screening. We sought to identify modifiable, clinic-level factors that distinguish primary care clinics with higher vs lower FIT completion rates in response to a centralized mailed FIT program.
METHODS: We used baseline observational data from 15 clinics within a single urban federally qualified health center participating in a pragmatic trial to optimize a mailed FIT program. Clinic-level data included interviews with leadership using a guide informed by the Consolidated Framework for Implementation Research (CFIR) and FIT completion rates. We used template analysis to identify explanatory factors and configurational comparative methods to identify specific combinations of clinic-level conditions that uniquely distinguished clinics with higher and lower FIT completion rates.
RESULTS: We interviewed 39 clinic leaders and identified 58 potential explanatory factors representing clinic workflows and the CFIR inner setting domain. Clinic-level FIT completion rates ranged from 30% to 56%. The configurational model for clinics with higher rates (≥37%) featured any 1 of the following 3 factors related to support staff: (1) adding back- or front-office staff in past 12 months, (2) having staff help patients resolve barriers to CRC screening, and (3) having staff hand out FITs/educate patients. The model for clinics with lower rates involved the combined absence of these same 3 factors.
CONCLUSIONS: Three factors related to support staff differentiated clinics with higher and lower FIT completion rates. Adding nonphysician support staff and having those staff provide enabling services might help clinics optimize mailed FIT screening programs.

Keywords

Associated Data

ClinicalTrials.gov | NCT03167125

References

  1. Acad Med. 2015 Oct;90(10):1347-52 [PMID: 26039141]
  2. J Racial Ethn Health Disparities. 2018 Jun;5(3):530-535 [PMID: 28634873]
  3. BMC Health Serv Res. 2019 May 9;19(1):298 [PMID: 31072316]
  4. Contemp Clin Trials. 2018 Apr;67:11-15 [PMID: 29408304]
  5. Cochrane Database Syst Rev. 2019 Jan 28;1:CD011651 [PMID: 30687940]
  6. Implement Sci. 2020 Sep 15;15(1):77 [PMID: 32933525]
  7. Gastroenterology. 2020 Oct;159(4):1205-1208 [PMID: 32682766]
  8. Ann Fam Med. 2019 Jan;17(1):36-41 [PMID: 30670393]
  9. Transl Behav Med. 2017 Sep;7(3):557-566 [PMID: 28150097]
  10. Am J Prev Med. 2020 Feb;58(2):224-231 [PMID: 31786031]
  11. Isr J Health Policy Res. 2020 Mar 23;9(1):12 [PMID: 32204734]
  12. Ann Fam Med. 2019 Sep;17(5):448-458 [PMID: 31501208]
  13. JAMA Intern Med. 2018 Dec 1;178(12):1645-1658 [PMID: 30326005]
  14. J Ambul Care Manage. 2004 Jul-Sep;27(3):242-8 [PMID: 15287214]
  15. JMIR Cancer. 2020 Oct 29;6(2):e21697 [PMID: 33027039]
  16. Implement Sci Commun. 2021 Jan 11;2(1):5 [PMID: 33431063]
  17. Health Aff (Millwood). 2019 Sep;38(9):1468-1474 [PMID: 31479374]
  18. Prev Med. 2017 Aug;101:44-52 [PMID: 28506715]
  19. J Am Board Fam Med. 2019 May-Jun;32(3):307-317 [PMID: 31068395]
  20. Prev Med. 2019 Dec;129S:105836 [PMID: 31635848]
  21. BMC Cancer. 2022 Jan 25;22(1):106 [PMID: 35078444]
  22. Implement Sci. 2020 Oct 21;15(1):92 [PMID: 33087156]
  23. J Gen Intern Med. 2016 Oct;31(10):1190-7 [PMID: 27279097]
  24. Prev Med. 2019 Jan;118:113-121 [PMID: 30367972]
  25. J Mix Methods Res. 2016 Jul;10(3):251-272 [PMID: 27429602]
  26. Transl Behav Med. 2021 Mar 16;11(2):540-548 [PMID: 32083287]
  27. Implement Sci. 2009 Aug 07;4:50 [PMID: 19664226]
  28. BMC Health Serv Res. 2019 Mar 25;19(1):189 [PMID: 30909897]
  29. Annu Rev Public Health. 2019 Apr 1;40:423-442 [PMID: 30633710]
  30. J Natl Cancer Inst. 2014 Apr;106(4):dju032 [PMID: 24681602]
  31. Int J Nurs Stud. 2015 Mar;52(3):727-43 [PMID: 25577306]
  32. Implement Sci. 2020 Dec 11;15(1):108 [PMID: 33308250]
  33. BMC Fam Pract. 2017 Feb 2;18(1):13 [PMID: 28148227]
  34. Ann Fam Med. 2021 May-Jun;19(3):240-248 [PMID: 34180844]
  35. Transl Behav Med. 2015 Mar;5(1):60-7 [PMID: 25729454]
  36. CA Cancer J Clin. 2020 Jul;70(4):283-298 [PMID: 32583884]
  37. J Am Board Fam Med. 2017 Sep-Oct;30(5):632-644 [PMID: 28923816]
  38. Health Policy. 2019 Jun;123(6):550-563 [PMID: 30955711]
  39. Gerontologist. 2020 Nov 23;60(8):1566-1574 [PMID: 32440672]
  40. J Gen Intern Med. 2022 Apr;37(5):1073-1080 [PMID: 34047921]
  41. Eur J Cancer Prev. 2018 May;27(3):227-236 [PMID: 28665812]
  42. Med Care Res Rev. 2021 Feb;78(1_suppl):7S-17S [PMID: 33074038]
  43. JAMA Health Forum. 2020 May;1(5): [PMID: 34532717]
  44. BMC Cancer. 2018 Jan 06;18(1):40 [PMID: 29304835]
  45. EGEMS (Wash DC). 2017 Jun 14;5(1):13 [PMID: 29930961]
  46. J Gen Intern Med. 2020 Nov;35(Suppl 2):815-822 [PMID: 33107003]
  47. EGEMS (Wash DC). 2017 Dec 07;5(1):28 [PMID: 29881744]
  48. J Ambul Care Manage. 1997 Oct;20(4):32-8 [PMID: 10181621]
  49. JAMA. 2016 Jun 21;315(23):2564-2575 [PMID: 27304597]
  50. J Am Board Fam Med. 2019 Mar-Apr;32(2):180-190 [PMID: 30850454]
  51. Br J Gen Pract. 2017 Nov;67(664):523-524 [PMID: 29074695]
  52. Trials. 2020 Jan 15;21(1):91 [PMID: 31941527]
  53. J Health Care Poor Underserved. 2020;31(2):845-858 [PMID: 33410811]
  54. Prev Chronic Dis. 2019 Aug 15;16:E107 [PMID: 31418685]
  55. Med Care. 2020 May;58(5):e31-e38 [PMID: 32187105]

Grants

  1. K07 CA211971/NCI NIH HHS
  2. U01 MD010665/NIMHD NIH HHS

MeSH Term

Colorectal Neoplasms
Early Detection of Cancer
Humans
Mass Screening
Occult Blood
Postal Service

Word Cloud

Created with Highcharts 10.0.0FITclinicsratesstafffactorscompletionscreeninghigherlowermailedsupportidentifyhealthconfigurational3MailedfecalimmunochemicalprogramscolorectalcancerCRCclinic-levelprimarycareprogramuseddatafederallyqualifiedcenterpragmatictrialoptimizeClinic-levelCFIRexplanatorycomparativemethodsclinicmodel1relatedhelppatientsPURPOSE:testcanfacilitatesoughtmodifiabledistinguishvsresponsecentralizedMETHODS:baselineobservational15withinsingleurbanparticipatingincludedinterviewsleadershipusingguideinformedConsolidatedFrameworkImplementationResearchtemplateanalysisspecificcombinationsconditionsuniquelydistinguishedRESULTS:interviewed39leadersidentified58potentialrepresentingworkflowsinnersettingdomainranged30%56%≥37%featuredfollowingstaff:addingback-front-officepast12months2resolvebarriershandFITs/educateinvolvedcombinedabsenceCONCLUSIONS:ThreedifferentiatedAddingnonphysicianprovideenablingservicesmightClinicFactorsAssociatedFecalImmunochemicalTestCompletion:Difference-MakingRoleSupportStafftestingpractice-basedresearch

Similar Articles

Cited By